中心静脉-动脉血二氧化碳分压差/动脉-中心静脉血氧含量差与脓毒症发生病情恶化风险的相关性

黄伟; 马耀; 孙风来; 裴学勇; 黄伟; 马耀; 孙风来; 裴学勇

doi:10.13898/j.cnki.issn.1000-2200.2022.08.016

[1]

宋迎春, 任国庆. 降钙素原、动脉血乳酸水平及中心静脉-动脉血二氧化碳分压差(Pcv-aCO₂)在脓毒症患者预后评估中的临床意义[J]. 吉林医学, 2018, 39(9): 1621. doi: 10.3969/j.issn.1004-0412.2018.09.008

[2]

WIRZ Y, MEIER MA, BOUADMA L, et al. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials[J]. Crit Care, 2018, 22(1): 191. doi: 10.1186/s13054-018-2125-7

[3]

MESQUIDA J, SALUDES P, GRUARTMONER G, et al. Central venous-toarterial carbon dioxide difference combined with arterial-to-venous oxygen content difference is associated with lactate evolution in early septic shock[J]. Crit Care, 2015, 19: 126. doi: 10.1186/s13054-015-0858-0

[4]

李洲山, 程丹. 降钙素原异常升高预警早期脓毒血症的临床诊治分析[J]. 内科急危重症杂志, 2021, 27(1): 86.

[5]

CHOL JJ, MCARTHY MW. Novel applications for serum procalcitonin testing in clinical practice[J]. Expert Rev Mol Diagn, 2018, 18(1): 27. doi: 10.1080/14737159.2018.1407244

[6]

王中华, 温剑艺, 李汉彪, 等. 中心静脉-动脉血二氧化碳分压差对老年脓毒症患者预后的评估价值[J]. 中华危重病急救医学, 2018, 30(8): 727. doi: 10.3760/cma.j.issn.2095-4352.2018.08.003

[7]

YANG S, QI H, KAN K, et al. Neutrophil extracellular traps promote hypercoagulability in patients with sepsis[J]. Shock, 2017, 47(2): 132. doi: 10.1097/SHK.0000000000000741

[8]

中国医师协会急诊医师分会, 中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/脓毒性休克急诊治疗指南(2018)[J]. 感染、炎症、修复, 2019, 20(1): 3. doi: 10.3969/j.issn.1672-8521.2019.01.001

[9]

温莉玲, 陈家佳, 梁红丽. 尿NGAL、KIM-1联合APACHEⅡ评分对脓毒症急性肾损伤诊断及预后的价值[J]. 临床急诊杂志, 2019, 20(2): 110.

[10]

HASAN GM, AL-EYADHY AA, TEMSAH MA, et al. Feasibility and efficacy of sepsis management guidelines in a pediatric intensive care unit in Saudi Arabia: a quality improvement initiative[J]. Int J Qual Health Care, 2018, 30(8): 587. doi: 10.1093/intqhc/mzy077

[11]

ONG DSY, FRENCKEN JF, KLEIN KLOUWENBERG PMC, et al. Short-course adjunctive gentamicin as empirical therapy in patients with severe sepsis and septic shock: A prospective observational cohort study[J]. Clin Infect Dis, 2017, 64(12): 1731. doi: 10.1093/cid/cix186

[12]

LUKAS P, DURILA M, JONAS J, et al. Evaluation of thromboelastometry in sepsis in correlation with bleeding during invasive procedures[J]. Clin Appl Thromb Hemost, 2018, 24(6): 993. doi: 10.1177/1076029617731624

[13]

OFOMA UR, DAHDAH J, KETHIREDDY S, et al. Case volume-outcomes associations among patients with severe sepsis who underwent interhospital transfer[J]. Crit Care Med, 2017, 45(4): 615. doi: 10.1097/CCM.0000000000002254

[14]

陈静波. C-反应蛋白、降钙素原对脓毒症患者早期诊断及病情评估的应用价值[J]. 国际检验医学杂志, 2020, 41(2): 242. doi: 10.3969/j.issn.1673-4130.2020.02.029

[15]

MOUSTAFA AA, ANTONIOS MA, ABDELLATIF EM, et al. Association of lactate/albumin ratio level to organ failure and mortality in severe sepsis in a pediatric intensive care unit in Egypt[J]. Turk J Pediatr, 2018, 60(6): 691. doi: 10.24953/turkjped.2018.06.010

[16]

孟祥海, 章宏伟, 张淑兰. 重症肺炎患者预后和APACHEⅡ评分及降钙素原PCT水平变化的关系[J/CD]. 现代医学与健康研究电子杂志, 2018, 2(1): 30.

[17]

张运君, 卓小岸, 周小曼, 等. 血清降钙素原、C-反应蛋白及乳酸对老年脓毒症患者的预后评估[J]. 中华老年多器官疾病杂志, 2018, 17(1): 47.

[18]

石玉娜, 周晓燕, 王庆海, 等. 脓毒症患者血清降钙素原表达及其对预后的影响分析[J]. 国际检验医学杂志, 2018, 39(9): 1059. doi: 10.3969/j.issn.1673-4130.2018.09.010

[19]

HE H, LONG Y, LIU D, et al. The prognostic value of central venousto-arterial CO₂ difference/arterial-central venous O₂ difference ratio in septic shock patients with central venous O₂ saturation ≥ 80[J]. Shock, 2017, 48(5): 551. doi: 10.1097/SHK.0000000000000893

[20]

王雪婷, 高雪花, 曹雯, 等. 血乳酸联合中心静脉-动脉血二氧化碳分压差与动脉-中心静脉血氧含量差比值预测脓毒性休克患者预后的应用价值[J]. 中华危重病急救医学, 2020(1): 39.